Manel Peiró - Academia.edu (original) (raw)
Papers by Manel Peiró
Revista De Calidad Asistencial, 2006
Journal of Information Technology Teaching Cases
Healthcare and life science companies are transforming their business models from product develop... more Healthcare and life science companies are transforming their business models from product development toward precision medicine. Vasant Narasimhan was appointed in 2018 as the new CEO of Novartis—a global pharma company. He champions a multi-faceted strategic intent: 1) transform the company from “selling pills” to investing heavily in discovering of new treatments that combine life sciences and digital technologies. In Spain, José Marcilla, the Director General of Novartis Oncology, pioneered an organizational transformation by developing (1) a cell-based innovation organization and process and (2) a new startup accelerator. This case explores both initiatives and their far-reaching consequences. The “Spanish experiment” helped to develop of digital services that reach the patient in a highly regulated environment. This duo of cases—Novartis Oncology Spain: Agile Innovation and The RWE (real wold evidence) Cell—gives students the opportunity to examine the motivations behind the tr...
Revista Española de Cardiología (English Edition), 2012
A thorough understanding of some of the conceptual aspects of strategic planning (SP) is essentia... more A thorough understanding of some of the conceptual aspects of strategic planning (SP) is essential before it can be effectively implemented. Unless such understanding is achieved-which is not always the case-the process may be approached in a superficial manner, which is a common cause for the failure of SP. Definition of Strategic Planning There are many academic definitions, as well as others which, although not academic, have been applied successfully by those employing them. 1 This demonstrates that what matters is the importance of the concept and idea behind the definition, rather than the definition itself. Strategic planning is the systematic and organized process whereby an organization creates a document indicating the way it plans to progress from its current situation to the desired future situation. It is the set of decision-making criteria and the decisions taken and implemented by an organization to definitively and permanently guide its activities and structure. We would like to highlight 2 important aspects: First, it is assumed that the unit of production is not the individual but the organization. There is still a long way to go before it is fully recognized that a health professional working alone, even with sufficient material resources available, cannot
Revista Española de Cardiología, 2012
Revista de Calidad Asistencial, 2006
Revista Española de Cardiología, 2012
Formalisation en occam et simulation sur un réseau de Transputers d'un processeur systolique de t... more Formalisation en occam et simulation sur un réseau de Transputers d'un processeur systolique de traitement d'images Description in occam and simulation on a Transputer network of a systolic processor for image processing Alain PIRSON C .E .A. D .LETI/DSYS/SETIA , Centre d'études Nucléaires, 38041 GRENOBLE CEDEX. Alain Pirson est né en 1963 à Namur en Belgique. Il obtient en 1986 le grade d'Ingénieur Civil Électricien à l'Université Catholique de Louvain (Belgique). Il mène ensuite une activité de recherche à la division LETI du Commissariat à l'Énergie Atomique dans le cadre d'un Plan de Stimulation des Coopérations et des Échanges Scientifiques et Techniques Européens. Spécialisé dans les architectures parallèles pour le traitement d'images, il
Annals of Hematology
Among the different biomarkers predicting response in chronic lymphocytic leukemia (CLL), the mos... more Among the different biomarkers predicting response in chronic lymphocytic leukemia (CLL), the most influential parameters are the mutational status of the IGHV genes and the presence of TP53 gene disruptions. Nevertheless, these important assessments are not readily available in most centers dealing with CLL patients. To provide this molecular testing across the country, the Spanish Cooperative Group on CLL (GELLC) established a network of four analytical reference centers. A total of 2153 samples from 256 centers were analyzed over a period of 30 months. In 9% of the patients, we found pathological mutations in the TP53 gene, whereas 48.96% were classified as IGHV unmutated. Results of the satisfaction survey of the program showed a Net Promoter Score of 85.15. Building a national network for molecular testing in CLL allowed the CLL population a broad access to complex biomarkers analysis that should translate into a more accurate and informed therapeutic decision-making.
Tempus Actas de Saúde Coletiva
Os sistemas de saúde contribuíram claramente para melhorar o estado de saúde da população, mas a ... more Os sistemas de saúde contribuíram claramente para melhorar o estado de saúde da população, mas a taxa de crescimento dos gastos em saúde, superior à do crescimento do PIB nos países desenvolvidos, levanta questões sobre sua sustentabilidade. No entanto, a análise da sustentabilidade tende a ser parcial: concentra-se nos gastos com a saúde e, raramente, na cobertura e nas receitas fiscais do sistema de saúde, um ponto crítico no caso da Espanha. Neste artigo analisamos o impacto da crise econômica na sustentabilidade do sistema de saúde espanhol, e não apenas seu impacto econômico, mas também em termos de aumento de saúde e desigualdades. E, finalmente, uma estimativa do crescimento dos gastos de saúde pública em Espanha para os próximos anos em um cenário de reforma e um cenário de crescimento sem mudanças estruturais, para trazer para fora o custo de não fazer nada é feito. Mudanças e reformas tornam-se imperativas, mas isso requer um clima de discussão calma e aberta que envolva t...
Medicina clínica, Jan 22, 2005
Revista De Calidad Asistencial, 2006
Journal of Information Technology Teaching Cases
Healthcare and life science companies are transforming their business models from product develop... more Healthcare and life science companies are transforming their business models from product development toward precision medicine. Vasant Narasimhan was appointed in 2018 as the new CEO of Novartis—a global pharma company. He champions a multi-faceted strategic intent: 1) transform the company from “selling pills” to investing heavily in discovering of new treatments that combine life sciences and digital technologies. In Spain, José Marcilla, the Director General of Novartis Oncology, pioneered an organizational transformation by developing (1) a cell-based innovation organization and process and (2) a new startup accelerator. This case explores both initiatives and their far-reaching consequences. The “Spanish experiment” helped to develop of digital services that reach the patient in a highly regulated environment. This duo of cases—Novartis Oncology Spain: Agile Innovation and The RWE (real wold evidence) Cell—gives students the opportunity to examine the motivations behind the tr...
Revista Española de Cardiología (English Edition), 2012
A thorough understanding of some of the conceptual aspects of strategic planning (SP) is essentia... more A thorough understanding of some of the conceptual aspects of strategic planning (SP) is essential before it can be effectively implemented. Unless such understanding is achieved-which is not always the case-the process may be approached in a superficial manner, which is a common cause for the failure of SP. Definition of Strategic Planning There are many academic definitions, as well as others which, although not academic, have been applied successfully by those employing them. 1 This demonstrates that what matters is the importance of the concept and idea behind the definition, rather than the definition itself. Strategic planning is the systematic and organized process whereby an organization creates a document indicating the way it plans to progress from its current situation to the desired future situation. It is the set of decision-making criteria and the decisions taken and implemented by an organization to definitively and permanently guide its activities and structure. We would like to highlight 2 important aspects: First, it is assumed that the unit of production is not the individual but the organization. There is still a long way to go before it is fully recognized that a health professional working alone, even with sufficient material resources available, cannot
Revista Española de Cardiología, 2012
Revista de Calidad Asistencial, 2006
Revista Española de Cardiología, 2012
Formalisation en occam et simulation sur un réseau de Transputers d'un processeur systolique de t... more Formalisation en occam et simulation sur un réseau de Transputers d'un processeur systolique de traitement d'images Description in occam and simulation on a Transputer network of a systolic processor for image processing Alain PIRSON C .E .A. D .LETI/DSYS/SETIA , Centre d'études Nucléaires, 38041 GRENOBLE CEDEX. Alain Pirson est né en 1963 à Namur en Belgique. Il obtient en 1986 le grade d'Ingénieur Civil Électricien à l'Université Catholique de Louvain (Belgique). Il mène ensuite une activité de recherche à la division LETI du Commissariat à l'Énergie Atomique dans le cadre d'un Plan de Stimulation des Coopérations et des Échanges Scientifiques et Techniques Européens. Spécialisé dans les architectures parallèles pour le traitement d'images, il
Annals of Hematology
Among the different biomarkers predicting response in chronic lymphocytic leukemia (CLL), the mos... more Among the different biomarkers predicting response in chronic lymphocytic leukemia (CLL), the most influential parameters are the mutational status of the IGHV genes and the presence of TP53 gene disruptions. Nevertheless, these important assessments are not readily available in most centers dealing with CLL patients. To provide this molecular testing across the country, the Spanish Cooperative Group on CLL (GELLC) established a network of four analytical reference centers. A total of 2153 samples from 256 centers were analyzed over a period of 30 months. In 9% of the patients, we found pathological mutations in the TP53 gene, whereas 48.96% were classified as IGHV unmutated. Results of the satisfaction survey of the program showed a Net Promoter Score of 85.15. Building a national network for molecular testing in CLL allowed the CLL population a broad access to complex biomarkers analysis that should translate into a more accurate and informed therapeutic decision-making.
Tempus Actas de Saúde Coletiva
Os sistemas de saúde contribuíram claramente para melhorar o estado de saúde da população, mas a ... more Os sistemas de saúde contribuíram claramente para melhorar o estado de saúde da população, mas a taxa de crescimento dos gastos em saúde, superior à do crescimento do PIB nos países desenvolvidos, levanta questões sobre sua sustentabilidade. No entanto, a análise da sustentabilidade tende a ser parcial: concentra-se nos gastos com a saúde e, raramente, na cobertura e nas receitas fiscais do sistema de saúde, um ponto crítico no caso da Espanha. Neste artigo analisamos o impacto da crise econômica na sustentabilidade do sistema de saúde espanhol, e não apenas seu impacto econômico, mas também em termos de aumento de saúde e desigualdades. E, finalmente, uma estimativa do crescimento dos gastos de saúde pública em Espanha para os próximos anos em um cenário de reforma e um cenário de crescimento sem mudanças estruturais, para trazer para fora o custo de não fazer nada é feito. Mudanças e reformas tornam-se imperativas, mas isso requer um clima de discussão calma e aberta que envolva t...
Medicina clínica, Jan 22, 2005